Micron's 2027 EPS to Exceed $100! Barclays "Super Double" Forecast Far Surpasses Market Consensus of $54

This earnings report and guidance have pushed the “memory cycle” narrative into a more aggressive range: revenue, gross margin, and cash flow are all rising simultaneously, forcing the market’s previous valuation center of profit to move upward. Barclays has raised its 2027 EPS forecast to triple digits, with the target price increased from $450 to $675, maintaining an Overweight rating; based on the March 18 closing price of $461.73, this implies approximately 46% upside.

Barclays analyst Tom O’Malley directly states in the latest report that the company’s revenue guidance “exceeds Wall Street expectations by 42%, with gross margin guidance reaching 81%,” which fundamentally changes our model, and we now expect 2027 EPS to surpass $100. The Bloomberg consensus (as of March 18) for Micron’s FY2027 EPS is $54.81, a significant gap.

The core supporting this “super doubling” model is not a sudden demand recovery but rather tight supply: Barclays believes DRAM and NAND will remain in an extremely tight supply-demand balance until 2026. Management mentioned that key customers can only meet 50%–67% of their mid-term needs, making prices harder to move quickly.

This optimism does not ignore headwinds: the company expects PC and smartphone shipments to decline by low double digits in 2026. However, Barclays focuses on the faster consumption of memory in data centers and AI—three factors reinforce this: HBM roadmap, capital expenditure expansion, and signing of a five-year strategic customer agreement, all providing greater visibility and higher profit leverage.

What triggers the “model reset” are the figures in the guidance

In the February quarter, Micron’s performance exceeded expectations along with pricing elasticity: revenue of $2.39 billion (vs. Wall Street’s $1.97 billion), adjusted gross margin of 74.9% (vs. 69.1%), EPS of $12.20 (vs. $9.00). DRAM revenue was $1.88 billion, NAND revenue $500 million, both above consensus.

What truly made the market re-evaluate was the May quarter guidance: revenue of $3.35 billion (vs. $2.37 billion), gross margin of 81.0% (vs. 72.4%), operating expenses guidance of $140 million, below the expected $151 million, corresponding to Barclays’ estimated EPS of $19.15 (vs. Wall Street’s $11.29).

Prices are still rising

Barclays attributes nearly all of this earnings upgrade to “tight supply-driven strong pricing + cost execution + product mix.” The February quarter data provides direct evidence: DRAM shipments grew by “single digits” quarter-over-quarter, ASP increased by “mid-60%”; NAND shipments grew by “low single digits,” ASP increased by “high 70%.”

By the May quarter, Barclays continues to bet on ASP increases: DRAM ASP +34% QoQ, NAND ASP +43%, assuming industry supply remains tight.

“Customers can only meet 50%–67% of demand”

The most significant management feedback in the report is that key customers can only meet 50%–67% of their mid-term needs. Barclays directly infers: the price environment will persist and will not peak rapidly within a single quarter.

Supply-side constraints are also more specific: DRAM supply growth is limited by cleanroom space, construction cycles, higher HBM conversion ratios, and “bits per wafer decreasing”; NAND is similarly constrained by cleanroom space, with some suppliers shifting resources to DRAM.

HBM roadmap has entered delivery rhythm

Barclays views “rising AI memory content” as the main variable for cycling through the cycle. The company disclosed that it began shipping HBM4 12H 36GB (for NVIDIA Vera Rubin platform) in Q1 2026, and is sampling HBM4 16H 48GB; HBM4E is in development, expected to ramp in 2027.

When asked about Groq’s LPU and its SRAM usage during the conference call, the company responded that its impact is “more additive”: AI evolution will drive higher HBM/DRAM content in standard racks, rather than replacing memory demand.

PCs and smartphones are declining, data centers are increasing their share

Management expects PC and smartphone shipments to decline by low double digits in 2026. However, data center volumes are growing: the company expects that in 2026, the bit TAM for data center DRAM and NAND will surpass 50% of the entire industry TAM for the first time; server shipments are expected to grow by low double digits, with new platforms also increasing per-server DRAM content.

Cash flow and capital expenditure are expanding in tandem

Barclays emphasizes that this cycle is not about “low investment to squeeze profits.” Management expects FQ3 cash flow to double quarter-over-quarter (FQ2 was $5.5 billion), with Barclays estimating FQ3 cash flow at $13.7 billion, and capex for that quarter around $7 billion.

Capital expenditure directions are clearer: the company guides FY26 net capex to exceed $25 billion (previously about $20 billion), mainly driven by cleanroom investments; FY27 total capex will significantly increase, with related construction capex rising by over $10 billion year-over-year to support HBM and DRAM investments.

Five-year SCA and Tongluo expansion

The company announced its first five-year strategic customer agreement (SCA), unlike the usual 1-year LTA, aiming to improve business stability and visibility; simultaneously, it plans to start construction of a second cleanroom of similar scale at Tongluo (acquired from Lattice) by the end of FY26 for DRAM.

Within Barclays’ framework, these two initiatives extend the “good prices” from a short-term boom into a longer-term certainty.

Target price raised, valuation multiple lowered

Barclays raised the target price from $450 to $675 but also lowered the valuation multiple: the new target is based on 6.3x CY27 EPS of $106.77; previously, $450 was based on 11.1x CY27 EPS of $40.46. The multiple was reduced because they expect price growth to slow from here, but profit base to be significantly elevated.

The profit gap itself is the conclusion: Barclays’ adjusted FY2027 EPS forecast is $102.53, far above Bloomberg consensus of $54.81; FY2026 EPS forecast is $57.91, also higher than consensus of $37.54.

Upside of $800, downside of $400

The report provides clear scenario boundaries: an upside of $800, valuing at 7x CY27 EPS of $115, assuming faster HBM growth, stronger pricing, and better cost performance; a downside of $400, valuing at 4.7x CY27 EPS of $85, assuming AI demand weakens, supply expands aggressively, and price declines last longer than expected.

Barclays’ core bet is explicit: as long as tight supply persists into 2026 and HBM ramps as planned, triple-digit EPS is no longer a peak fantasy but a main assumption they are willing to realize with their target price.

Risk warnings and disclaimers

Market risks exist; investments should be cautious. This article does not constitute personal investment advice and does not consider individual users’ specific investment goals, financial situations, or needs. Users should consider whether any opinions, views, or conclusions herein are suitable for their particular circumstances. Invest at your own risk.